Updated 3:03 p.m. ET, December 11, 2020
- The US Food and Drug Administration's advisory committee recommended the agency grant emergency-use authorization to Pfizer’s coronavirus vaccine. A US Centers for Disease Control and Prevention committee is meeting this weekend to consider if the vaccine should be offered to the American public.
- Health experts are warning it's likely the US won't see any meaningful, widespread impacts from vaccinations until well into 2021.
- Canada granted emergency approval for the vaccine after health officials determined it met safety, efficacy and quality requirements.